Company / Current Assets per Share
Larimar Therapeutics, Inc. Current Assets per Share History
FY2014-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$1.92
FY2019
5-year range
$1.92 / $8.22
FY2015-FY2019
Trend
-56.6%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $3.84 to $1.92 over the past 2 years.
Based on SEC 10-K filings.
1.92 in FY2019 with a 5-year CAGR of -58.8%.
Declined from $3.84 to $1.92 over the past 2 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -26.4%
- 5-Year CAGR
- -58.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, current assets per share decreased 56.6% year-over-year.
- Peak current assets per share was recorded in FY2014.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -4.64 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $1.92 | -56.6% |
| FY2018 | $4.41 | +15.0% |
| FY2017 | $3.84 | -20.1% |
| FY2016 | $4.80 | -41.6% |
| FY2015 | $8.22 | -94.9% |
| FY2014 | $160.68 | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026